Targeting escape mutations
in hematological cancers
with first and best in class medicines

A small molecule oncology drug discovery company that is committed to defeating cancer. 

Lomond Therapeutics, a precision hematology company, is the development stage spinout from Eilean Therapeutics - a biopharma targeting resistant mutation in hematological and solid cancer malignancies.

Our Recent News

Lomond Therapeutics Announces Upcoming Presentation at the ASH Annual Meeting